Data from Alternating 17beta-estradiol and aromatase inhibitor therapies is efficacious in post-menopausal women with advanced endocrine-resistant ER+ breast cancer
Authors:
- Gary N. SchwartzGSGary N. Schwartz
- Peter A. KaufmanPKPeter A. Kaufman
- Karthik V. GiridharKGKarthik V. Giridhar
- Jonathan D. MarottiJMJonathan D. Marotti
- Mary D. ChamberlinMCMary D. Chamberlin
- Bradley A. ArrickBABradley A. Arrick
- Grace Makari-JudsonGMGrace Makari-Judson
- Matthew P. GoetzMGMatthew P. Goetz
- Shannon M. SoucySSShannon M. Soucy
- Fred KollingFKFred Kolling
- Eugene DemidenkoEDEugene Demidenko
- Todd W. MillerTMTodd W. Miller
Open Access
- 16 September 2024
- other
- Published by American Association for Cancer Research (AACR)